NUCLEIC ACID COMPLEX
Developed and provided is: a nucleic acid agent that is efficiently delivered to the central nervous system, to which drug delivery is inhibited by the blood brain barrier mechanism, and that provides an antisense effect to a target transcription product at the delivery site; and a composition conta...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Sasaki, Shigekazu Tokunoh, Ryosuke Furukawa, Hideki Yogo, Takatoshi Yokota, Takanori Hidaka, Kosuke Seki, Tomohiro Nagata, Tetsuya Uchida, Akio Miyata, Kenichi Nakagawa, Yasuo |
| description | Developed and provided is: a nucleic acid agent that is efficiently delivered to the central nervous system, to which drug delivery is inhibited by the blood brain barrier mechanism, and that provides an antisense effect to a target transcription product at the delivery site; and a composition containing such a nucleic acid agent. Provided is a double-stranded nucleic acid complex consisting of a first nucleic acid strand and a second nucleic acid strand that are annealed to each other; wherein the first nucleic acid strand hybridizes with part of a target transcription product and has an antisense effect on the target transcription product; and wherein the second nucleic acid strand includes a base sequence complementary to the first nucleic acid strand and is conjugated to a phosphatidylethanolamine or an analog thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2023295628A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2023295628A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2023295628A13</originalsourceid><addsrcrecordid>eNrjZBDxC3X2cfV0VnB09nRRcPb3DfBxjeBhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRsZGlqZmRhaOhsbEqQIA4fMfaQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NUCLEIC ACID COMPLEX</title><source>esp@cenet</source><creator>Sasaki, Shigekazu ; Tokunoh, Ryosuke ; Furukawa, Hideki ; Yogo, Takatoshi ; Yokota, Takanori ; Hidaka, Kosuke ; Seki, Tomohiro ; Nagata, Tetsuya ; Uchida, Akio ; Miyata, Kenichi ; Nakagawa, Yasuo</creator><creatorcontrib>Sasaki, Shigekazu ; Tokunoh, Ryosuke ; Furukawa, Hideki ; Yogo, Takatoshi ; Yokota, Takanori ; Hidaka, Kosuke ; Seki, Tomohiro ; Nagata, Tetsuya ; Uchida, Akio ; Miyata, Kenichi ; Nakagawa, Yasuo</creatorcontrib><description>Developed and provided is: a nucleic acid agent that is efficiently delivered to the central nervous system, to which drug delivery is inhibited by the blood brain barrier mechanism, and that provides an antisense effect to a target transcription product at the delivery site; and a composition containing such a nucleic acid agent. Provided is a double-stranded nucleic acid complex consisting of a first nucleic acid strand and a second nucleic acid strand that are annealed to each other; wherein the first nucleic acid strand hybridizes with part of a target transcription product and has an antisense effect on the target transcription product; and wherein the second nucleic acid strand includes a base sequence complementary to the first nucleic acid strand and is conjugated to a phosphatidylethanolamine or an analog thereof.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230921&DB=EPODOC&CC=US&NR=2023295628A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230921&DB=EPODOC&CC=US&NR=2023295628A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Sasaki, Shigekazu</creatorcontrib><creatorcontrib>Tokunoh, Ryosuke</creatorcontrib><creatorcontrib>Furukawa, Hideki</creatorcontrib><creatorcontrib>Yogo, Takatoshi</creatorcontrib><creatorcontrib>Yokota, Takanori</creatorcontrib><creatorcontrib>Hidaka, Kosuke</creatorcontrib><creatorcontrib>Seki, Tomohiro</creatorcontrib><creatorcontrib>Nagata, Tetsuya</creatorcontrib><creatorcontrib>Uchida, Akio</creatorcontrib><creatorcontrib>Miyata, Kenichi</creatorcontrib><creatorcontrib>Nakagawa, Yasuo</creatorcontrib><title>NUCLEIC ACID COMPLEX</title><description>Developed and provided is: a nucleic acid agent that is efficiently delivered to the central nervous system, to which drug delivery is inhibited by the blood brain barrier mechanism, and that provides an antisense effect to a target transcription product at the delivery site; and a composition containing such a nucleic acid agent. Provided is a double-stranded nucleic acid complex consisting of a first nucleic acid strand and a second nucleic acid strand that are annealed to each other; wherein the first nucleic acid strand hybridizes with part of a target transcription product and has an antisense effect on the target transcription product; and wherein the second nucleic acid strand includes a base sequence complementary to the first nucleic acid strand and is conjugated to a phosphatidylethanolamine or an analog thereof.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBDxC3X2cfV0VnB09nRRcPb3DfBxjeBhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRsZGlqZmRhaOhsbEqQIA4fMfaQ</recordid><startdate>20230921</startdate><enddate>20230921</enddate><creator>Sasaki, Shigekazu</creator><creator>Tokunoh, Ryosuke</creator><creator>Furukawa, Hideki</creator><creator>Yogo, Takatoshi</creator><creator>Yokota, Takanori</creator><creator>Hidaka, Kosuke</creator><creator>Seki, Tomohiro</creator><creator>Nagata, Tetsuya</creator><creator>Uchida, Akio</creator><creator>Miyata, Kenichi</creator><creator>Nakagawa, Yasuo</creator><scope>EVB</scope></search><sort><creationdate>20230921</creationdate><title>NUCLEIC ACID COMPLEX</title><author>Sasaki, Shigekazu ; Tokunoh, Ryosuke ; Furukawa, Hideki ; Yogo, Takatoshi ; Yokota, Takanori ; Hidaka, Kosuke ; Seki, Tomohiro ; Nagata, Tetsuya ; Uchida, Akio ; Miyata, Kenichi ; Nakagawa, Yasuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2023295628A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>Sasaki, Shigekazu</creatorcontrib><creatorcontrib>Tokunoh, Ryosuke</creatorcontrib><creatorcontrib>Furukawa, Hideki</creatorcontrib><creatorcontrib>Yogo, Takatoshi</creatorcontrib><creatorcontrib>Yokota, Takanori</creatorcontrib><creatorcontrib>Hidaka, Kosuke</creatorcontrib><creatorcontrib>Seki, Tomohiro</creatorcontrib><creatorcontrib>Nagata, Tetsuya</creatorcontrib><creatorcontrib>Uchida, Akio</creatorcontrib><creatorcontrib>Miyata, Kenichi</creatorcontrib><creatorcontrib>Nakagawa, Yasuo</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Sasaki, Shigekazu</au><au>Tokunoh, Ryosuke</au><au>Furukawa, Hideki</au><au>Yogo, Takatoshi</au><au>Yokota, Takanori</au><au>Hidaka, Kosuke</au><au>Seki, Tomohiro</au><au>Nagata, Tetsuya</au><au>Uchida, Akio</au><au>Miyata, Kenichi</au><au>Nakagawa, Yasuo</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NUCLEIC ACID COMPLEX</title><date>2023-09-21</date><risdate>2023</risdate><abstract>Developed and provided is: a nucleic acid agent that is efficiently delivered to the central nervous system, to which drug delivery is inhibited by the blood brain barrier mechanism, and that provides an antisense effect to a target transcription product at the delivery site; and a composition containing such a nucleic acid agent. Provided is a double-stranded nucleic acid complex consisting of a first nucleic acid strand and a second nucleic acid strand that are annealed to each other; wherein the first nucleic acid strand hybridizes with part of a target transcription product and has an antisense effect on the target transcription product; and wherein the second nucleic acid strand includes a base sequence complementary to the first nucleic acid strand and is conjugated to a phosphatidylethanolamine or an analog thereof.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2023295628A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | NUCLEIC ACID COMPLEX |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T12%3A06%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Sasaki,%20Shigekazu&rft.date=2023-09-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2023295628A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |